TY  - JOUR

T1  - Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer

JO  - Urologic Oncology: Seminars and Original Investigations

UR  - https://doi.org/10.1016/j.urolonc.2024.12.264

PY  - 2025/01/15

AU  - Daneshmand S

AU  - Kamat AM

AU  - Shore ND

AU  - Meeks JJ

AU  - Galsky MD

AU  - Jacob JM

AU  - van der Heijden MS

AU  - Williams SB

AU  - Powles T

AU  - Chang SS

AU  - Catto JWF et al

ED  - 

DO  - DOI: 10.1016/j.urolonc.2024.12.264

PB  - Elsevier BV

Y2  - 2025/02/05

ER  -